Tus-Pharmaceutical Group Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 274.63 million compared to CNY 236.55 million a year ago. Revenue was CNY 274.63 million compared to CNY 236.55 million a year ago.

Net income was CNY 6.43 million compared to CNY 15.7 million a year ago. Basic earnings per share from continuing operations was CNY 0.0269 compared to CNY 0.0656 a year ago. Diluted earnings per share from continuing operations was CNY 0.0269 compared to CNY 0.0656 a year ago.